Role of Fibulin-1 in APP Processing
Fibulin-1 在 APP 处理中的作用
基本信息
- 批准号:8581789
- 负责人:
- 金额:$ 22.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:Abeta synthesisAddressAlkaline PhosphataseAlzheimer&aposs DiseaseAmyloidAmyloid beta-ProteinAmyloid beta-Protein PrecursorAmyloid depositionBehaviorBindingBrainCellsCognitiveConditioned Culture MediaDementiaDevelopmentDisintegrinsEmbryoEngineeringEnzymesEpidermal Growth FactorEtiologyEventExtracellular Matrix ProteinsFamilyFibroblastsFunctional disorderGene DeletionGoalsHeparin BindingKnockout MiceLeadMediatingMembraneMetalloproteasesMusNeuregulin 1NeuroblastomaNeurodegenerative DisordersNeuronsPathogenesisPeptidesPhorbol EstersPlayProcessProductionProteolysisProteolytic ProcessingRoleSenile PlaquesSmall Interfering RNATestingTherapeuticTherapeutic InterventionTransgenic MiceTransgenic Organismsalpha secretaseamyloid precursor protein processingbasebeta secretasebrain cellcellular engineeringcombatfibulin 1gamma secretaseinhibitor/antagonistinterestmemberoverexpressionpublic health relevancesecretasetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): Many current pharmacological approaches to combating Alzheimer's disease (AD) seek to block Abeta production through inhibition of the amyloidogenic enzymes known as beta- and gamma-secretases. An alternative approach is to activate the alpha-secretase processing of amyloid precursor protein (APP), which is mediated by several members of the disintegrin family of metalloproteases, ADAM9, ADAM10 and ADAM17. Processing of APP by these alpha-secretases is thought to be beneficial with respect to AD since it limits production of Abeta and generates the neuroprotective soluble APPalpha (sAPPalpha) product. Fibulin-1 (Fbln1) is an extracellular matrix protein, expressed in the brain by neurons, that binds the amino terminus of APP and sAPPalpha. The significance of this interaction is not yet established however, we have found that Fbln1 also binds to other membrane anchored alpha-secretase substrates, heparin binding-epidermal growth factor (HB-EGF) and neuregulin-1 (NRG1). We also show that Fbln1 acts to inhibit the proteolytic release of soluble forms of HB-EGF and NRG1. Furthermore, we have found increased levels of sAPPalpha in the conditioned culture medium of Fbln1 null mouse embryo fibroblasts (MEFs) as compared to wildtype MEFs. Based on these findings it is hypothesized that Fbln1 serves as an inhibitor of alpha-secretase processing of APP and therefore may represent a therapeutic target that if inhibited might lead to augmented alpha-secretase processing of APP and reduced pathological APP cleavage. To address this hypothesis there are three specific aims: 1) Determine whether brain APP proteolytic cleavage is altered in Fbln1-deficient mice, 2) determine whether transgenic overexpression of Fbln1 accelerates Abeta production and exacerbates AD pathogenesis, and 3) determine whether Fbln1 inhibits alpha-secretase processing of APP in cultured neuronal cells.
描述(由申请人提供):对抗阿尔茨海默氏病(AD)的许多当前药理方法试图通过抑制称为β-和γ-分泌酶的淀粉样蛋白酶生成酶来阻止Abeta产生。另一种方法是激活淀粉样蛋白前体蛋白(APP)的α-分泌酶加工,该加工是由金属蛋白酶的分解蛋白家族ADAM9,ADAM9,ADAM10和ADAM17介导的。这些α-分泌酶对APP的处理在AD方面被认为是有益的,因为它限制了Abeta的产生并生成神经保护性可溶性appalpha(Sappalpha)产品。 Fibulin-1(FBLN1)是一种细胞外基质蛋白,通过神经元在大脑中表达,它结合了App和Sappalpha的氨基末端。但是,尚未确定这种相互作用的重要性,我们发现FBLN1还与其他膜锚定α-分泌酶底物,肝素结合 - 表皮生长因子(HB-EGF)和Neuregulin-1(NRG1)结合。我们还表明,FBLN1的作用是抑制HB-EGF和NRG1可溶性形式的蛋白水解释放。此外,与WildType MEF相比,我们发现在FBLN1 NULL小鼠胚胎成纤维细胞(MEF)的条件培养基中,sappalpha的水平增加。基于这些发现,假设FBLN1是APP的α-分泌酶处理的抑制剂,因此可能代表了一个治疗靶标,即如果被抑制可能会导致APP的α-分泌酶处理增加并减少病理APP裂解。要解决这一假设,有三个具体的目的:1)确定在FBLN1缺陷型小鼠中是否改变了脑应用蛋白水解裂解,2)确定FBLN1的转基因过表达是否会加速Abeta的产生和加剧AD AD AD AD AD AD AD病原体,3)确定FBLN1是否确定FBLN1是否抑制了Alpha Alpha Alpha Alpha Alpha Alpha iNUDIND ALPHA INPHIS ALPHAININD ALPHA INFLININD ALPHA INPHININD ALPHAINIS AIN FIND FIND FIND FINDIND AIN FIND FINDIND ALPHAIND INDING ALPHA。 - 培养的神经元细胞中APP的分泌酶处理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KELLEY M ARGRAVES其他文献
KELLEY M ARGRAVES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KELLEY M ARGRAVES', 18)}}的其他基金
S1P Deficiency Prolongs Endothelial Barrier Recovery After Fontan Operation
S1P 缺乏可延长 Fontan 手术后内皮屏障的恢复
- 批准号:
8444397 - 财政年份:2012
- 资助金额:
$ 22.43万 - 项目类别:
S1P Deficiency Prolongs Endothelial Barrier Recovery After Fontan Operation
S1P 缺乏可延长 Fontan 手术后内皮屏障的恢复
- 批准号:
8302043 - 财政年份:2012
- 资助金额:
$ 22.43万 - 项目类别:
HDL-Associated S1P as an Indicator of Relative Risk for Cardiovascular Disease
HDL 相关 S1P 作为心血管疾病相对风险的指标
- 批准号:
7739654 - 财政年份:2009
- 资助金额:
$ 22.43万 - 项目类别:
HDL-Associated S1P as an Indicator of Relative Risk for Cardiovascular Disease
HDL 相关 S1P 作为心血管疾病相对风险的指标
- 批准号:
7904887 - 财政年份:2009
- 资助金额:
$ 22.43万 - 项目类别:
SC COBRE: SPHINGOSINE1PHOSPHATE IN EARLY BLOOD VESSEL FORMATION
SC COBRE:早期血管形成中的磷酸鞘氨醇
- 批准号:
7610441 - 财政年份:2007
- 资助金额:
$ 22.43万 - 项目类别:
SC COBRE: SPHINGOSINE1PHOSPHATE IN EARLY BLOOD VESSEL FORMATION
SC COBRE:早期血管形成中的磷酸鞘氨醇
- 批准号:
7381846 - 财政年份:2006
- 资助金额:
$ 22.43万 - 项目类别:
Sphingosine-1-phosophate signaling in vasculogenesis
1-磷酸鞘氨醇信号传导在血管发生中的作用
- 批准号:
6908722 - 财政年份:2005
- 资助金额:
$ 22.43万 - 项目类别:
SC COBRE: SPHINGOSINE1PHOSPHATE IN EARLY BLOOD VESSEL FORMATION
SC COBRE:早期血管形成中的磷酸鞘氨醇
- 批准号:
7171076 - 财政年份:2005
- 资助金额:
$ 22.43万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Elucidating the role of Myosin 5b in intestinal inflammation
阐明肌球蛋白 5b 在肠道炎症中的作用
- 批准号:
10883872 - 财政年份:2023
- 资助金额:
$ 22.43万 - 项目类别:
Predicting neonatal health outcomes from placental and fetal brain extracellular vesicles in pregnant opioid users
通过妊娠阿片类药物使用者的胎盘和胎儿脑细胞外囊泡预测新生儿健康结果
- 批准号:
10747661 - 财政年份:2023
- 资助金额:
$ 22.43万 - 项目类别:
Project 4 - Mechanisms of pyrophosphate dysregulation
项目 4 - 焦磷酸盐失调的机制
- 批准号:
10628931 - 财政年份:2023
- 资助金额:
$ 22.43万 - 项目类别:
Bioengineering Phage-based Biosensors with Genetic Specificity and High Sensitivity
具有遗传特异性和高灵敏度的生物工程噬菌体生物传感器
- 批准号:
10727412 - 财政年份:2023
- 资助金额:
$ 22.43万 - 项目类别:
Mechanosensing of osteoclasts in periodontitis.
牙周炎中破骨细胞的机械传感。
- 批准号:
10752476 - 财政年份:2023
- 资助金额:
$ 22.43万 - 项目类别: